1030 results about "Biosynthetic product" patented technology

The invention relates to the technical field of biosynthesis, and particularly discloses a pyridone compound as well as a biosynthesis method and application thereof. On the basis of related technologies of synthetic biology, non-ribosome peptide synthetase is modified, non-ribosome peptide synthetase mutants are heterologously expressed in various hosts, a pyridone compound is found and obtained for the first time, the chemical molecular formula of the pyridone compound is determined to be C5H4N2O3, and the pyridone compound is named as 5-aminopyridine-2, 3, 6-triketone or 5-hydroxy-3-iminopyridine-2, 3, 6-triketone or 5-hydroxy-3-iminopyridine-2, 3, 6-triketone or 5-hydroxy-3-iminopyridine-2, 3, 6-triketone. The novel pyridone compound can be used as a raw material or an intermediate to be applied to development and preparation of novel antibiotics, drugs and dyes.

The invention discloses a deoxyartemisinin B synthase and an application of an isoenzyme A0A2U1PPI9 of the deoxyartemisinin B synthase in catalysis of dihydroartemisinin acid for biosynthesis of dihydrodeoxyartemisinin B. The invention further discloses a preparation method of the deoxyartemisinin B synthase. The invention discloses a process for biosynthesizing dihydrodeoxidized artemisinin B from dihydroartemisinin for the first time in a biosynthesis pathway of artemisinin, and bioinformatics analysis and in-vitro activity verification of candidate enzymes show that both the deoxidized artemisinin B synthase and the isoenzyme A0A2U1PPI9 have a new function of catalyzing the biosynthesis of dihydrodeoxidized artemisinin B from dihydroartemisinin, so that the application of the deoxidized artemisinin B synthase and the isoenzyme A0A2U1PPI9 to the biosynthesis of dihydrodeoxidized artemisinin B is developed. Lines of artemisinin biosynthetic pathways are enriched, and a theoretical basis is provided for analysis of terminal biosynthetic pathways of artemisinin and heterologous synthesis of artemisinin compounds.

Composites of metal-organic framework particles and bacterial cellulose, methods of making the composites, and methods of using the composites in the hydrolysis of organic compounds are provided. The composites, which are aerogels comprising metal-organic framework particles embedded in a bacterial cellulose nanofiber network, are fabricated using a microbial synthesis strategy in which bacterial cellulose nanofiber is biosynthesized using a cellulose-producing bacteria in a fermentation medium in which metal-organic framework particles are dispersed.

The invention relates to the technical field of biology, in particular to application of N-terminal truncated 8-isopentenyl transferase in production of 8-isopentene kaempferol. The invention provides the N-terminal truncated 8-isopentenyl transferase, and the N-terminal truncated 8-isopentenyl transferase can be used for carrying out isopentenylation on kaempferol to generate 8-isopentene kaempferol. Specifically, the saccharomyces cerevisiae is used as a chassis, under the condition that kaempferol is exogenously added, through overexpression of 8-isopentenyl transferase, biosynthesis of 8-isopentenyl kaempferol in the saccharomyces cerevisiae is realized, and meanwhile, a foundation is laid for subsequent biosynthesis of icaritin. The invention provides a novel reference scheme for biosynthesis of flavonoid compounds.

The invention provides an application of citrus flavonoid glycosyl transferase CitUGT73A78 in biosynthesis of flavonoid glycoside, and belongs to the technical field of gene engineering and enzyme engineering. According to the present invention, the function of the CitUGT73A78 gene is cloned and verified, and the in vitro enzyme activity test proves that the CitUGT73A78 recombinant protein has broad-spectrum catalytic activity, and can efficiently catalyze the glucosylation of a variety of flavonoids so as to generate the corresponding flavonoids 7-O-glucoside and / or flavonoids 4 '-O-glucoside. An in-vivo transient overexpression test also proves that the CitUGT73A78 gene has a promoting effect on the accumulation of the content of the citrus flavonoid 7-O-glucoside. The invention not only provides a preparation method for the production of flavonoid 4 '-O-glucoside, has the advantages of simplicity, convenience, high catalytic efficiency, low cost, greenness and safety, but also can be applied to nutritional quality improvement and germplasm innovation of citrus fruits.

The invention discloses a tryptophan enzyme mutant and application thereof. The tryptophan enzyme mutant is obtained by mutation of at least one site of the 50th amino acid L, the 394th amino acid V and the 395th amino acid E of a tryptophan enzyme parent. The tryptophan enzyme mutant disclosed by the invention has good substrate bias, particularly has better selectivity and catalytic efficiency on 6 '-halogenated tryptophan, and not only simplifies the production process, but also improves the production efficiency when being used for biosynthesis production of the tylosin.

The invention relates to a method for biosynthesizing zero-valent nano-selenium by utilizing pantoea, the method comprises the following steps of: adding selenite into a strain culture medium, culturing pantoea, and separating and purifying from a synthetic product to obtain the zero-valent nano-selenium, the strain name of the pantoea is XZ-1, the classification name is pantoea Pantoeasp., the preservation number is CGMCC No.32330, the collection number is CGMCC No.32330, the collection number is CGMCC No.32330, the collection number is CGMCC No.32330, the collection number is CGMCC No.32330, the collection number is CGMCC No.32330, and the collection number is CGMCC No.32330. The preservation date is October 24, 2024, the strain XZ-1 is applied to synthesize zero-valent nano-selenium, biological nano-selenium is obtained from the synthesized product after multiple times of separation and purification, and the purified biological nano-selenium is mixed with a protective agent and a dispersing agent according to a certain proportion to prepare a nano-selenium fertilizer raw material, so that the problems that the nano-selenium is agglomerated and is easy to oxidize and lose efficacy are solved; the bioavailability of selenium is obviously improved, and the selenium element loss is reduced. The prepared nano-selenium can be used for original ingredients of fertilizers and feeds.

Provided is a method for biosynthesis of a human structural material type IV collagen. Provided herein is a recombinant collagen, comprising sequences as shown in SEQ ID NO: 1 and the like. The recombinant collagen herein has good cell adhesion activity. The method herein relates to using the genetic engineering technology to produce the recombinant collagen, and overcomes defects in the prior art.

This application relates to the field of biosynthesis technology, and specifically discloses a pyridone compound, its biosynthesis method and application. Based on synthetic biology-related technologies, this application modifies non-ribosomal peptide synthetase, heterologously expresses non-ribosomal peptide synthetase mutants in a variety of hosts, and for the first time discovers and obtains a pyridone compound, and determines its chemical formula as C5H4N2O3, named 5-amino-pyridine-2,3,6-trione or 5-hydroxy-3-imino-pyridine-2,6-dione. This novel pyridone compound can be used as a raw material or intermediate in the development and preparation of novel antibiotics, drugs and dyes.

The invention relates to recombinant streptomyces avermitilis, a construction method of the recombinant streptomyces avermitilis and application of the recombinant streptomyces avermitilis in preparation of combined vermectin B. The recombinant streptomyces avermitilis is streptomyces avermitilis HU510 preserved in China Center for Type Culture Collection (CCTCC), the preservation date is October 9, 2024, and the preservation number of the strain is CCTCC NO: M 20242151. The invention relates to the technical field of synthetic biology, in particular to a method for preparing and producing a novel biological insecticide, and particularly relates to a method for preparing recombinant insect-killing streptomyces of combined vermectin B. The streptomyces sp. Has an aveA3 gene which is inactivated or reduced in activity, and has a functional milA3 gene. According to the invention, efficient production of the combined vermectin B can be realized. According to the invention, a biological synthetic method and technology are utilized to recombine and transform a biosynthetic pathway of abamectin, and the novel insecticidal antibiotic is obtained through screening.

The invention discloses a biosynthetic bacterial cellulose-based solid electrolyte as well as a preparation method and application thereof, and belongs to the technical field of solid electrolytes. The solid electrolyte is prepared by taking modified bacterial cellulose prepared by fermenting acetobacter xylinum, rhizobium, pseudomonas, azospirillum, alcaligenes and other bacteria as a substrate, introducing a low-molecular-weight polymer to regulate and control the arrangement of cellulose molecular chains to serve as a conductive ion framework, and then compounding a conductive ion high-molecular-weight polymer and a lithium salt. According to the invention, cellulose molecular chains are modified by modified glucose, and a network structure is regulated and controlled by a low-molecular-weight polymer, so that the problems of small spacing, lack of ion coordination sites and weak ion transmission capability of pure cellulose molecular chains are effectively solved, the ionic conductivity of the prepared solid electrolyte can reach 10 <-4 > S cm <-1 >, the electrochemical window width reaches 5V, and the solid electrolyte has a good application prospect. The material can tolerate high critical current density, is suitable for various positive electrode materials, and is suitable for high-voltage and long-cycle-life energy storage devices.

The invention discloses a methanophilic genetically engineered bacterium for producing trehalose as well as a construction method and application of the methanophilic genetically engineered bacterium, and belongs to the technical field of industrial biology. The methanophilic genetically engineered bacterium capable of producing the trehalose is obtained by taking methanophilic bacteria methanophilic 5GB1, Alkalicicus glycogenes WONF2802 or methanophilic bacteria NG09 as host bacteria, introducing maltooligosyl trehalose synthase (MTS) into the host bacteria, and carrying out over-expression on maltooligosyl trehalose hydrolase (MTH), so as to obtain the methanophilic genetically engineered bacterium capable of producing the trehalose. Under the condition that methane or methanol serves as a carbon source, the yield of the produced trehalose can reach the gram level or above, a new low-carbon biosynthesis way can be provided for commercial production of the trehalose, and the methanophilic genetically engineered bacterium for producing the trehalose has a good industrial application prospect.

The invention relates to the field of biological engineering and technology, in particular to an enzyme for synthesizing glabridin, a biological synthesis method of glabridin and a bacterial strain. The invention discloses a series of glabridin synthesizing enzymes (phenylalanine ammonialyase, cinnamic acid-4-hydrogenase, tyrosine ammonialyase, p-coumaric acid coenzyme A ligase, chalcone synthase, chalcone reductase, chalcone isomerase, isoflavone synthase, 2-hydroxyisoflavone dehydratase, 4 '-oxymethyltransferase, 4'-hydroxymethyltransferase and 4 '-hydroxymethyltransferase) derived from glycyrrhiza glabra for the first time. ) can be used in the preparation of a compound (e.g., isoflavone 2 '-hydrogenase, isoflavone reductase, Vissisoketoreductase, isoprenyltransferase, pterocarpin reductase, oxidative cyclase, demethylase, cytochrome P450 reductase, and the like). The de novo synthesis of the glabridin in a microbial cell factory is realized for the first time, and the application prospect of the glabridin biological manufacturing industry is greatly promoted.

The invention discloses a phoebe zhennan PzGGPS12 gene and application of the phoebe zhennan PzGGPS12 gene to improvement of yield and drought tolerance of plant terpenoids, and belongs to the field of genetic engineering, a key enzyme gene PzGGPS12 for catalyzing biosynthesis of the terpenoids in phoebe zhennan wood is screened and analyzed, and a full-length CDS nucleic acid sequence of the PzGGPS12 is obtained. Transgenic experiments prove that overexpression of the gene improves the relative content of tobacco monoterpenes and triterpenes. Short-term drought experiments prove that overexpression of the gene can promote biosynthesis of sesquiterpenes, diterpenes and triterpenes so as to enhance drought tolerance of transgenic tobacco. Therefore, the gene can be introduced into a plant as a target gene, the yield of terpenoids in the plant is increased, and the drought tolerance of the plant is enhanced so as to improve the variety of the plant.

The invention discloses a production method for biosynthesis of rebaudioside M. Reb A / Reb D has poor solubility at a low temperature, and the reaction efficiency can be obviously accelerated when the Reb A / Reb D is catalytically produced in a high-temperature environment, so that the whole reaction system is carried out in the high-temperature environment, and the production efficiency can be improved. Under the reaction temperature environment of 70 DEG C, the wild type first glycosyltransferase or / and the wild type second glycosyltransferase are / is basically inactivated, and the catalytic enzyme combination cannot meet the requirement of industrial biosynthesis of rebaudioside M. The wild-type catalytic enzyme is mutated, so that the wild-type catalytic enzyme can keep high catalytic activity at 70 DEG C. Therefore, the production cost of the rebaudioside M produced by the production method disclosed by the invention is obviously lower than that of the prior art, and the method is suitable for industrial popularization.

The application discloses a galactosyltransferase mutant and application thereof in preparation of flavonoid compounds, and belongs to the technical field of enzymology. The application provides a UDP-galactosyltransferase mutant, which is obtained by site-directed mutation of one amino acid in the amino acid sequence of wild-type galactosyltransferase VcUFGT into alanine (A). The effects of a series of mutants H82A, V139A, G141A, P186A, N245A, V282A and S307A are verified in the examples, the mutants can perform enzyme catalysis reaction with quercetin and UDP-galactoside as substrates, and generate flavonoid compound hyperoside, and the specific enzyme activity of the mutants is more than 1.5 times that of the wild type, thereby providing an effective application basis for biosynthesis of flavonoid compounds.

The present invention discloses a broad-spectrum antibacterial peptide, and the amino acid sequence of the antibacterial peptide is GECEGNNRPVKKPQPRKKLPRFKKC-NH2. Based on melittin, the present invention designs antibacterial peptides by predicting based on a deep learning model, and obtains antibacterial peptides with broad-spectrum bacteriostasis, thermal stability and low hemolytic property, which have good inhibitory effects on skin pathogenic bacteria such as Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Candida albicans and Propionibacterium acnes. Peptides predicted as AMP amino acid sequences by the deep learning model antibacterial peptide prediction tool amPEPpy are selected for screening, and by using a biosynthesis technique, they are expressed, extracted and purified in Escherichia coli, reducing the workload and screening period of screening, and increasing the probability of screening out broad-spectrum and thermally stable biosynthetic antibacterial peptides.

The invention discloses a phenanthridine-6-formaldehyde derivative and a preparation method and application thereof.The preparation method comprises the steps that 2, 4, 5, 6-tetra (9-carbazolyl)-isophthalonitrile serves as a photocatalyst, 1-azabicyclo [2.2. 2] octane serves as a hydrogen atom transfer catalyst, a biphenyl isocyanide compound, the photocatalyst, the hydrogen atom transfer catalyst and an alkali additive are jointly dissolved in 1, 3-dioxolane, the mixture is stirred to be uniform, and the phenanthridine-6-formaldehyde derivative is obtained. And carrying out free radical tandem cyclization and acid-catalyzed hydrolysis reaction to obtain the phenanthridine-6-formaldehyde derivative. The invention also provides a specific reaction equation. According to the developed synthesis method of the phenanthridine-6-formaldehyde derivative, the compound can be efficiently and conveniently prepared, the technical bottlenecks of harsh reaction conditions and tedious steps in a traditional process are successfully overcome, raw materials which are low in price and easy to obtain are adopted, operation is carried out under mild conditions, the synthesis method has the outstanding advantages of being high in yield, safe and simple to operate, environmentally friendly and the like, and the method is suitable for industrial production. Good industrial application potential is shown.

The invention discloses a recombinant bacterium for fermentation production of D-panthenol and application of the recombinant bacterium. The invention relates to the technical field of biology, and provides a recombinant bacterium for fermentation production of D-panthenol, which is obtained by expressing tyrosine decarboxylase and D-pantothenic acid synthetase in a chassis host bacterium, the chassis host bacteria are escherichia coli capable of synthesizing D-pantoic acid and L-homoserine by using glucose. Compared with an existing chemical synthesis method, pure biosynthesis from glucose to D-panthenol is achieved, the method has the advantages of being environmentally friendly, low in cost and the like, and a good foundation is laid for large-scale industrial production of D-panthenol.

The invention relates to the technical field of enzyme engineering, in particular to an acylase mutant and a biosynthesis method of (R)-2-aminobutanol.The acylase mutant comprises at least one of mutation of the following sites relative to wild type acylase with the amino acid sequence being SEQ ID NO: 1: T106, A625 and S413. The acylase mutant disclosed by the invention is used for synthesizing (R)-2-aminobutanol through biological catalysis, and the reaction route is as follows: the catalytic efficiency of a product is remarkably improved by the mutant, and the ee value of a chiral product is improved; according to the synthesis method, the problem of chiral resolution in the prior art is solved, the production cost is reduced, and pollution is reduced.

The invention belongs to the technical field of biosynthesis, and particularly relates to an engineering bacterium for preparing stevioside through de novo fermentation as well as a preparation method and application of the engineering bacterium. According to the invention, mevalonate kinase in the MVA pathway is mutated and optimized. The method comprises the following steps: carrying out point mutation on mevalonate kinase MvK of a wild type source, constructing a stevioside synthesis route in an escherichia coli host, and comparing the influence of MvK mutation on the yield of stevioside, so as to determine a Q160L mutant, and applying the Q160L mutant to the stevioside production route to realize efficient production of stevioside.

The application discloses an acyltransferase mutant with high acetylation activity and application thereof, and belongs to the technical field of enzyme engineering. The acyltransferase mutant provided by the application contains one or more mutation sites in the 62th and 64th positions on the basis of the acyltransferase mutant with the amino acid sequence shown in SEQ ID NO. 1. The acyltransferase mutant obtained by the application has higher acyltransferase activity and catalytic efficiency than the original enzyme before mutation, and can improve the yield of N-acetyl-trans-4-hydroxyproline. Therefore, the acyltransferase mutant of the application has important significance in the efficient biosynthesis of N-acetyl-trans-4-hydroxyproline, and has wide application prospects in the fields of biological materials, medicines or cosmetics.

The invention discloses a transporter T6417 and application thereof in increasing the yield of natural products of streptomyces, and belongs to the technical field of genetic engineering. In order to improve the yield of a streptomyces natural product, the method comprises the following steps: screening transporters related to the yield and a production time sequence on the basis of analysis on transcriptome data of streptomyces cerevisiae NEAU6, and carrying out function annotation analysis to obtain a candidate transporter T6417; then, different promoters are used for carrying out adaptation on the expression of the T6417, and it is found that the yield of natural products can be increased by overexpressing the transporter T6417 in streptomyces obscurvius, streptomyces bingchengensis or streptomyces avermitilis. The invention provides a valuable biosynthetic element for efficient biomanufacturing of streptomyces.

To identify lipid metabolites that control Th17 cell differentiation and lipid biosynthetic enzymes involved therein, and based on that, to provide a screening method for a therapeutic agent for diseases caused by excessive Th17 cell responses.SOLUTION: Provided is 1-oleoyl-lysophosphatidylethanolamine (LPE(1-18:1)) as a lipid metabolic product that controls Th17 cell differentiation. Since LPE(1-18:1) binds to RORγt with high specificity and promotes differentiation into Th17 cells, a candidate compound for a therapeutic agent for diseases caused by excessive Th17 cell responses can be obtained by selecting a compound that inhibits the binding of LPE(1-18:1) to RORγt. Also provided are five lipid metabolic enzymes (Gpam, Gpat3, Lplat1, Pla2g12a, and Scd2) that are responsible for the biosynthesis of LPE(1-18:1) and control Th17 cell differentiation. By selecting a compound that inhibits the activity or expression of these lipid metabolic enzymes, a candidate compound for a therapeutic agent for diseases caused by excessive Th17 cell responses can be obtained.SELECTED DRAWING: None

The present invention provides a biomass gasification control system and a biomass gasification control method, and belongs to the field of biosynthesis, the biomass gasification control system comprises: a first-stage fluidized bed pyrolysis reactor for performing a preliminary pyrolysis reaction on a biomass raw material to obtain a pyrolysis reactant; the second-stage fluidized bed gasification reactor is used for carrying out gasification reaction on the pyrolysis reactant by utilizing various gasification agents to obtain target synthesis gas, including H2 and CO; wherein the multiple gasifying agents comprise oxygen, water vapor and carbon dioxide; the sensor monitoring module is used for monitoring real-time state data in the first-stage fluidized bed pyrolysis reactor and the second-stage fluidized bed gasification reactor; the central control module is used for sending out an adjusting instruction according to the real-time state data, and the adjusting instruction is used for adjusting and controlling the flow of the multiple gasifying agents, the rotating speed of the fan and the reaction temperature, so that the molar ratio of H2 to CO in the generated target synthesis gas is within a first threshold value range.

Provided is a method for biosynthesis of a human structural material type XVII collagen. The collagen comprises the amino acid sequence shown in SEQ ID NO: 2 or a variant amino acid sequence after mutation of the amino acid sequence. The variant amino acid sequence retains the function of the amino acid sequence as shown in SEQ ID NO: 2. The collagen can promote cell adhesion and has a triple helix structure.

The invention relates to a nano super-uniform titanium dioxide DGT binding film capable of efficiently adsorbing As and a preparation method thereof. Adsorption materials of As (III) and As (V), DGT devices and preparation methods thereof are covered. The material comprises a biosynthetic titanium dioxide modified binding membrane material Bio-TiO2-DGT, a diffusion membrane, a nitrocellulose membrane and the like. According to the method, metatitanic acid is taken as a raw material, biosynthesis is carried out by utilizing a strain XZ-1, and the Bio-TiO2-DGT binding membrane is prepared by in-situ precipitation of titanium dioxide. The preparation method disclosed by the invention is simple and easy to implement, and the obtained binding membrane material has the characteristics of good uniformity, nano-scale particle size of binding membrane particles, good adsorption performance on As (III) and As (V) and the like, and provides a technical support for two-dimensional high-resolution analysis of As. Meanwhile, the binding membrane not only overcomes the defects that a traditional TiO2 modified binding membrane is large in particle size, uneven, low in As adsorption capacity and the like, but also combines the advantages of biosynthesis and chemical precipitation, and has unique performance and potential application value.

The invention discloses a 7alpha-hydroxysteroid dehydrogenase mutant with improved catalytic activity as well as a coding gene and application thereof, and the amino acid sequence of the 7alpha-hydroxysteroid dehydrogenase mutant is obtained by mutation at one or more sites of the 120th site, the 195th site and the 207th site on the basis of the amino acid sequence shown in SEQ ID NO: 1. According to the 7alpha-HSDH mutant disclosed by the invention, the key site of the 7alpha-HSDH enzyme is modified, so that the mutant with higher activity than that of a wild enzyme is obtained, the efficiency bottleneck in UDCA biosynthesis is effectively broken through, and an efficient and green enzyme catalyst is provided for industrial application.

The invention discloses application of laccase as a catalyst in catalytic synthesis of allantoin. According to the invention, laccase from thermophilus is used as an enzyme catalyst, uric acid is oxidized, hydrolyzed and decarboxylated to synthesize allantoin, and efficient biosynthesis of allantoin is realized under mild conditions; wherein the amino acid sequence of the laccase derived from the thermophilic fungi is as shown in SEQ ID NO. 1. The invention provides an efficient, environment-friendly and low-cost biosynthesis approach for biosynthesis of allantoin, and has industrial application prospects in biosynthesis of allantoin.

The invention discloses application of bacillus subtilis BY-S1 in preparation of biological nano-selenium, and belongs to the technical field of microbiology and biological nano-selenium preparation. The preservation number of the bacillus subtilis BY-S1 is CCTCC (China Center for Type Culture Collection) NO: M 20232368. Research finds that the bacillus subtilis BY-S1 has the function of converting and synthesizing the biological nano-selenium by utilizing selenite, the strain BY-S1 and the biological nano-selenium converted and synthesized by the strain BY-S1 can remarkably promote plant growth, and when the bacillus subtilis BY-S1 and the biological nano-selenium are combined for use, a synergistic interaction effect is achieved. A new microbial resource is provided for biosynthesis of nano-selenium, a stable, safe and efficient nano-selenium preparation method is provided, and a theoretical basis is laid for research of a novel plant growth promoter.